Posted on 14/08/2009 in Pharmaceutical Company Product News Coloplast has released its interim financial statements for the first quarter of 2009 and has stated that they echo the positive trends the firm experienced during the first half of the year.
According to the group's data, its operating profits reached 989 million Danish Kroner (114.6 million pounds), representing an increase of 11 per cent compared to the same period in 2008.
Additionally, sales increased by five per cent during the first nine months of the current fiscal year, reaching a total of 6,558 Danish kroner, the firm's statistics show.
Coloplast has, as a result of this news, revised its financial guidance for the 2008/09 period, changing its profit margin forecast from 15 per cent to 16 per cent.
Lars Rasmussen, chief executive of the company, said: "I'm pleased that we've improved our profitability since last year, but then again, it's necessary in order to compete internationally."
One of Coloplast's most recent product launches took place in May with the introduction of its SenSura urostomy range.
Other news stories from 14/08/2009
Read more in the Zenopa News Archive
How this news is generated
|
